RenovoRx (RNXT)

• Market cap: $36.6M
• 1 day: -0.99%
• 5 days: 20.48%
• 1 month: 9.55%
• 3 months: 11.11%
• 6 months: -23.08%
• Year to date: 19.73%
• 1 year: 0.83%
• 5 years: -86.23%
• 10 years: -86.23%
• Sector: Healthcare
• Industry: Biotechnology

About: RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.

Employees: 10